Laddar...
Suvorexant: The first orexin receptor antagonist to treat insomnia
Primary insomnia is mainly treated with drugs acting on benzodiazepine receptors and a few other classes of drugs used for different co-morbidities. A novel approach to treat insomnia has been introduced recently, with the approval of suvorexant, the first in a new class of orexin receptor antagonis...
Sparad:
| I publikationen: | J Pharmacol Pharmacother |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Medknow Publications & Media Pvt Ltd
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419247/ https://ncbi.nlm.nih.gov/pubmed/25969666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.155496 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|